Byline: Anna Williams
-
Investigating Treatment for High-Risk Breast Cancer
A drug called bevacizumab added to adjuvant chemotherapy did not improve outcomes for patients with a form of high-risk breast cancer, according to a study published in the Journal of Clinical Oncology.
-
New Insights Into Cancer Metastasis
Northwestern Medicine scientists have discovered how circulating tumor cells cluster together during metastasis — findings that reveal a novel mechanism for how cancer spreads and a potential new target for treatment.
-
New Chair of Radiology Named
James Carr, MD, ’00 ’01 GME, the Knight Family Professor of Cardiac Imaging, has been named chair of the Department of Radiology.
-
Drug Improves Survival in Metastatic Breast Cancer
A drug called palbociclib, used in combination with standard treatment, improved survival for women with hormone receptor-positive metastatic breast cancer.
-
Quality of Life Holds Steady With Prostate Cancer Drug
In a recent clinical trial, a drug called apalutamide added to standard therapy slowed cancer progression in men with prostate cancer, while maintaining quality of life.
-
New Discovery Opens Path to Treatments for Hearing Loss
In a study published in Nature, Northwestern Medicine scientists have demonstrated that a gene is critical for the development of the ear’s outer hair cells, which has important implications for hearing loss treatments.
-
Addressing the Lack of Women in Orthopaedic Surgery
Linda Suleiman, MD, ’17 GME, assistant professor of Orthopaedic Surgery, discusses her recent study on the representation of women in orthopaedic surgery.
-
Drug Shows Promise for Progressive Multiple Sclerosis
An oral therapy called ibudilast significantly reduced the rate of brain tissue loss in patients with progressive multiple sclerosis, according to the results of a phase II trial.
-
Orkin Delivers Nemmers Prize Keynote Lecture
Stuart H. Orkin, MD, recipient of the 2018 Mechthild Esser Nemmers Prize in Medical Science, delivered a lecture at Feinberg about harnessing genetics to treat blood disorders.
-
Carvill Receives NIH New Innovator Award
Gemma Carvill, PhD, assistant professor of Neurology, has been named a recipient of the NIH Director’s New Innovator Award, which funds highly innovative research proposals with the potential to transform their field.
